Atlas Trials

Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT01188863 · COMPLETED

Trial details

NCT number
NCT01188863
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2010-09-01
Primary completion
2010-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.